4 年報 Annual Report 2022-23 我們的服務 HowWe Serve 1 新型工業化 – 香港製造 New Industrialisation —Made in Hong Kong 香港特區政府於2022年底推出《香港創新科技發 展藍圖》（《藍圖》），強調香港將完善創科生態圈、 推進新型工業化發展方向。新型工業化為「再工 業化」所取得的成果基礎上的進階版，透過工業 物聯網、人工智能、數據分析等先進技術，推 動企業和產業鏈邁向智能生產和綠色化，回應客 製化的市場趨勢，縮短產品從工廠到消費者的流 程，降低成本並進一步滿足市場需求，提高經濟 效益。 The HKSAR Government (the Government) launched the “Hong Kong Innovation and Technology Development Blueprint” (“Blueprint”) in late 2022, emphasising the development of a comprehensive I&T ecosystem and promoting the development direction of new industrialisation. New industrialisation is a further upgrade based on the achievements of “reindustrialisation” that promotes intelligent production and greening of enterprises and industry chains through advanced technologies such as industrial Internet of Things (IoT), artificial intelligence (AI), and data analysis. It meets the market trend of customisation, shortens the time from factory to consumer, reduces costs, and further satisfies market needs, thus improving economic efficiency. • 與香港生物醫藥創新協會公布《香港生命健 康產業發展研究》，研究留意到香港的生命健 康企業，特別在醫療和診斷設備、中藥和保 健食品這三大較具優勢的領域上，屬高增值 產業，值得大力推動。研究聚焦產業發展特 色、掌握行業情況、分析發展機遇、探討香 港業界應如何發揮優勢，及整合資源，為政 府及業界打造高增值生命健康產業鏈提供參 考。 • 與香港中文大學合作研發「近視風險因素監測 智能眼鏡」，旨在監測兒童的觀看習慣及近視 風險因素，從而減慢兒童近視加深的速度。 以上健康科技研發於「TechConnect世界創新 會議暨博覽會」上獲頒創新獎及「香港商業科 技卓越獎」。 • 為保心安藥廠有限公司研發內置實時數據採 集功能的全自動智慧GMP產品包裝設備#， 每小時可包裝3,000瓶藥油，滿足複雜和嚴格 的中藥產品包裝要求。項目勇奪「香港工程師 學會製造、工業及系統工業獎」及「智慧生活 夥伴大獎」。 生命健康科技 Life and HealthTechnology • Co-organised with the HK Bio-Med Innotech Association released the “Hong Kong Life and Health Industry Development Study”. The Study revealed that Hong Kong’s life and health enterprises are regarded as a high value-added industry worthy of active promotion, with three advantageous sectors warranting further clustering, namely medical and diagnostic equipment, Chinese medicine and health supplements. It offered an overview of the latest development and key attributes of this industry, and identified the future development opportunities. It served as a reference for the Government and industry stakeholders in formulating strategies to leverage Hong Kong’s strengths and consolidate resources to unleash the great potential of the high value-added life and health industry. • Developed “MY-O-Analyzer” with the Chinese University of Hong Kong to monitor the viewing habits and myopia risk factors of children, thereby slowing down their myopia progression. This HealthTech project garnered the “Innovation Award” at the TechConnect World Innovation Conference and Expo, and won the “Hong Kong Business Technology Excellence Awards”. • A fully-automated intelligent packaging system for GMP products# with built-in real-time data collection feature for Po Sum On Medicine Factory Limited, enabling the wrapping of 3,000 bottles of medicine oil per hour while complying with complex and strict packaging requirements of traditional Chinese medicine products. The project won the “HKIE MIS Industry Award” and the “Smart Living Partnership Award”. HKPC is proactively assisting enterprises in deploying digitalisation and greening of the global supply chain, as well as supporting the four broad development directions in the “Blueprint”, with a view to helping enterprises realise the goals of new industrialisation. 生產力局為企業提前部署，以順應全球供應鏈數 碼化、綠色化，以及配合《藍圖》所提出的四大 發展方向，助力企業實現新型工業化。 # 成功申請創新科技署「投資研發現金回贈計劃」 # Successfully applied for the Research and Development Cash Rebate Scheme under the ITC
RkJQdWJsaXNoZXIy Mjk0NjMy